INR 61.89
(1.13%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 4.38 Million INR | -15.97% |
2022 | 5.22 Million INR | 12.4% |
2021 | 4.64 Million INR | 8.12% |
2020 | 4.29 Million INR | -63.94% |
2019 | 11.92 Million INR | -27.2% |
2018 | 16.37 Million INR | 5.05% |
2017 | 15.58 Million INR | 9.14% |
2016 | 14.28 Million INR | 4.24% |
2015 | 13.69 Million INR | -54.03% |
2014 | 29.8 Million INR | 3.82% |
2013 | 28.7 Million INR | 2.72% |
2012 | 27.94 Million INR | 12.27% |
2011 | 24.89 Million INR | 91.77% |
2010 | 12.97 Million INR | -69.34% |
2009 | 42.34 Million INR | -17.67% |
2008 | 51.42 Million INR | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | - INR | -100.0% |
2023 Q4 | 4.38 Million INR | 0.0% |
2023 Q3 | - INR | -100.0% |
2023 FY | 4.38 Million INR | -15.97% |
2023 Q1 | - INR | -100.0% |
2023 Q2 | 5.64 Million INR | 0.0% |
2022 Q2 | 5.03 Million INR | 0.0% |
2022 Q3 | - INR | -100.0% |
2022 Q4 | 5.22 Million INR | 0.0% |
2022 FY | 5.22 Million INR | 12.4% |
2022 Q1 | - INR | -100.0% |
2021 Q1 | - INR | -100.0% |
2021 Q2 | 4.47 Million INR | 0.0% |
2021 Q3 | - INR | -100.0% |
2021 Q4 | 4.64 Million INR | 0.0% |
2021 FY | 4.64 Million INR | 8.12% |
2020 Q2 | 8.02 Million INR | 0.0% |
2020 Q1 | - INR | -100.0% |
2020 Q3 | - INR | -100.0% |
2020 FY | 4.29 Million INR | -63.94% |
2020 Q4 | 4.29 Million INR | 0.0% |
2019 FY | 11.92 Million INR | -27.2% |
2019 Q1 | - INR | -100.0% |
2019 Q2 | 14.37 Million INR | 0.0% |
2019 Q3 | - INR | -100.0% |
2019 Q4 | 11.92 Million INR | 0.0% |
2018 Q4 | 16.37 Million INR | 0.0% |
2018 FY | 16.37 Million INR | 5.05% |
2018 Q3 | - INR | -100.0% |
2018 Q2 | 16.28 Million INR | 0.0% |
2018 Q1 | - INR | -100.0% |
2017 FY | 15.58 Million INR | 9.14% |
2017 Q2 | 14.95 Million INR | 0.0% |
2017 Q4 | 15.58 Million INR | 0.0% |
2017 Q1 | - INR | -100.0% |
2017 Q3 | - INR | -100.0% |
2016 Q2 | 14.37 Million INR | 0.0% |
2016 Q1 | - INR | -100.0% |
2016 Q4 | 14.28 Million INR | 0.0% |
2016 FY | 14.28 Million INR | 4.24% |
2016 Q3 | - INR | -100.0% |
2015 Q2 | 30.14 Million INR | 0.0% |
2015 Q4 | 13.69 Million INR | 0.0% |
2015 FY | 13.69 Million INR | -54.03% |
2015 Q1 | - INR | -100.0% |
2015 Q3 | - INR | -100.0% |
2014 Q1 | 28.99 Million INR | 1.0% |
2014 Q3 | - INR | -100.0% |
2014 Q2 | 27.07 Million INR | -6.61% |
2014 Q4 | 29.8 Million INR | 0.0% |
2014 FY | 29.8 Million INR | 3.82% |
2013 Q3 | - INR | -100.0% |
2013 Q1 | - INR | -100.0% |
2013 FY | 28.7 Million INR | 2.72% |
2013 Q2 | 29.49 Million INR | 0.0% |
2013 Q4 | 28.7 Million INR | 0.0% |
2012 Q4 | 27.94 Million INR | 6.62% |
2012 Q2 | - INR | 0.0% |
2012 FY | 27.94 Million INR | 12.27% |
2012 Q3 | 26.2 Million INR | 0.0% |
2011 FY | 24.89 Million INR | 91.77% |
2011 Q4 | 24.89 Million INR | 0.0% |
2010 FY | 12.97 Million INR | -69.34% |
2009 FY | 42.34 Million INR | -17.67% |
2008 Q4 | 51.42 Million INR | 0.0% |
2008 FY | 51.42 Million INR | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Sigachi Industries Limited | 1.43 Billion INR | 99.693% |
Ind-Swift Limited | 10.13 Billion INR | 99.957% |
Bajaj HealthCare Limited | 3.32 Billion INR | 99.868% |
Sakar Healthcare Limited | 793.51 Million INR | 99.447% |
Aurobindo Pharma Limited | 66.47 Billion INR | 99.993% |
Innova Captab Limited | 2.45 Billion INR | 99.821% |
Divi's Laboratories Limited | 30 Million INR | 85.37% |
AstraZeneca Pharma India Limited | 45.98 Million INR | 90.455% |
Morepen Laboratories Limited | 289.99 Million INR | 98.487% |
Mankind Pharma Limited | 2.07 Billion INR | 99.788% |
Sequent Scientific Limited | 4.87 Billion INR | 99.91% |
Wanbury Limited | 1.16 Billion INR | 99.623% |
Laurus Labs Limited | 25.77 Billion INR | 99.983% |
Nectar Lifesciences Limited | 6.35 Billion INR | 99.931% |
Glenmark Life Sciences Limited | 171.48 Million INR | 97.441% |
Alembic Limited | 91.5 Million INR | 95.203% |
Hikal Limited | 8.17 Billion INR | 99.946% |
Alembic Pharmaceuticals Limited | 5.13 Billion INR | 99.914% |
Neuland Laboratories Limited | 953.89 Million INR | 99.54% |
J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | 99.884% |
Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 99.964% |
IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | 98.66% |
Themis Medicare Limited | 957.92 Million INR | 99.542% |
RPG Life Sciences Limited | - INR | -Infinity% |
Zydus Lifesciences Limited | 8.04 Billion INR | 99.945% |
Lupin Limited | 29.21 Billion INR | 99.985% |
Amrutanjan Health Care Limited | 17.28 Million INR | 74.605% |
Wockhardt Limited | 23.56 Billion INR | 99.981% |
Vaishali Pharma Limited | 134.91 Million INR | 96.747% |
Aarti Pharmalabs Limited | 2.85 Billion INR | 99.846% |
Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | 95.091% |
Jubilant Pharmova Limited | 36.64 Billion INR | 99.988% |
FDC Limited | 205.18 Million INR | 97.861% |
Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 99.978% |
Kilitch Drugs (India) Limited | 316.46 Million INR | 98.613% |
Eris Lifesciences Limited | 27.81 Billion INR | 99.984% |
Venus Remedies Limited | 413.3 Million INR | 98.938% |
ZIM Laboratories Limited | 1.08 Billion INR | 99.597% |
Bliss GVS Pharma Limited | 998.4 Million INR | 99.56% |
Par Drugs and Chemicals Limited | - INR | -Infinity% |
Caplin Point Laboratories Limited | 19.7 Million INR | 77.721% |
Shilpa Medicare Limited | 9.37 Billion INR | 99.953% |
Albert David Limited | 33.24 Million INR | 86.797% |
Ajanta Pharma Limited | 352.8 Million INR | 98.756% |
Hester Biosciences Limited | 2.44 Billion INR | 99.82% |
Suven Pharmaceuticals Limited | 649.96 Million INR | 99.325% |
Solara Active Pharma Sciences Limited | 10.11 Billion INR | 99.957% |
Gufic Biosciences Limited | 3.32 Billion INR | 99.868% |
Windlas Biotech Limited | 36.41 Million INR | 87.946% |
Procter & Gamble Health Limited | 95.6 Million INR | 95.409% |
Aarey Drugs & Pharmaceuticals Limited | 313.52 Million INR | 98.6% |
Mangalam Drugs & Organics Limited | 984.92 Million INR | 99.554% |
Granules India Limited | 13.15 Billion INR | 99.967% |
Aarti Drugs Limited | 5.64 Billion INR | 99.922% |
Bal Pharma Limited | 1.39 Billion INR | 99.686% |
Alkem Laboratories Limited | 14.18 Billion INR | 99.969% |
Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 99.987% |
Lincoln Pharmaceuticals Limited | 10.66 Million INR | 58.858% |
Medicamen Biotech Limited | 308.17 Million INR | 98.576% |
Unichem Laboratories Limited | 2.47 Billion INR | 99.823% |
Bafna Pharmaceuticals Limited | 243.89 Million INR | 98.2% |
Valiant Laboratories Limited | 767.08 Million INR | 99.428% |
Orchid Pharma Limited | 1.35 Billion INR | 99.675% |
Medico Remedies Limited | 80.5 Million INR | 94.548% |
Ind-Swift Laboratories Limited | 166.21 Million INR | 97.359% |
Ipca Laboratories Limited | 14.38 Billion INR | 99.969% |
Brooks Laboratories Limited | 56.41 Million INR | 92.221% |
Syncom Formulations (India) Limited | 724.86 Million INR | 99.395% |
Piramal Enterprises Limited | 535.85 Billion INR | 99.999% |
Torrent Pharmaceuticals Limited | 40.22 Billion INR | 99.989% |
NATCO Pharma Limited | 3.71 Billion INR | 99.882% |
Suven Life Sciences Limited | 7.09 Million INR | 38.157% |
Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 99.773% |
Strides Pharma Science Limited | 25.16 Billion INR | 99.983% |
Indoco Remedies Limited | 6.71 Billion INR | 99.935% |
Alpa Laboratories Limited | 52.46 Million INR | 91.634% |
Lasa Supergenerics Limited | 220.76 Million INR | 98.012% |
Sun Pharma Advanced Research Company Limited | 611.5 Million INR | 99.282% |